NCT00499122: NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer |
|
|
| Completed | 2 | 41 | US | Cyclophosphamide, Cytoxan, Docetaxel, Doxorubicin, Adriamycin, NOV 002, Oxidized glutathione | University of Miami | Breast Cancer | 04/11 | 04/11 | | |